Psychopharmacology retracted 3 papers on MDMA-assisted therapy due to unethical conduct at a study site, not part of Lykos Therapeutics' FDA application.
FDA rejected Lykos Therapeutics' MDMA therapy application citing missing data and study design issues, asking for an additional clinical trial, the company to appeal decision.
[
Collection
]
[
|
...
]